News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic


3/13/2014 11:05:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

March 13, 2014 -- TaiGen Biotechnology received marketing approval in Taiwan for Taigexyn® (nemonoxacin), a novel antibiotic that is aimed at community-acquired bacterial pneumonia. The approval is the first for TaiGen and for Taigexyn. In April 2013, TaiGen filed a new drug application for China approval of Taigexyn, which remains under review. Two years ago, TaiGen out-licensed China rights for Taigexyn to Zhejiang Medicine Co., which made an $8 million upfront payment. More details....

Stock Symbol: (TWO: 4157)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES